Abbott CEO Robert Ford explains how LAA and diabetes pressures drove Q3 guidance cuts, and what's ahead for 2027 growth.

The Secaucus, NJ-based company joins a long list of medtech and healthcare companies that have faced cyberattacks in 2026.

Following the premiere of You Can See Everything, a panel of women from the medtech industry unpacked the complicated, ...

Med-El launches TICI Unico, the first fully implanted cochlear implant offering 24/7 invisible hearing. Now CE-marked in ...

The proposed deal follows closely behind Labcorp announcing a deal to acquire certain laboratory testing businesses from ...

Edwards has recalled four lots of its Commander M delivery system after balloon bursts during inflation caused one patient ...

Many DFSS summaries park verification, validation, and process validation in one Verify box. Teams then “verify” on the bench ...

Paradromics is in collaboration with Siemens Healthineers to develop an advanced multimodal imaging platform designed to ...

The medical device industry is entering a new chapter of risk — one shaped not by a single technology shift, but by the accumulation of software, AI, and increasingly autonomous systems inside ...

Medtech M&A hit a decade-high $130B in 2026, but portfolio discipline, not blockbuster deals, is driving real shareholder ...

An expert shares tips on how to receive feedback with curiosity instead of defensiveness, encouraging viewers to seek ...

MD+DI's annual Salary Survey, fielded online from July 8 through September 8, 2026, drew 366 completed responses from full-time professionals working at medical device manufacturers, in vitro ...